Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO - The Christie Virtual Preceptorship on Lung Cancer 2020

ESMO-Preceptorship-Lung-Cancer-Virtual-2020-1000x250
Start date
19 Oct 2020
End date
21 Oct 2020
Location
Virtual, CEST Time
Application deadline
Closed

Please kindly note that the virtual course programme timings are to be considered CEST (Central European Summer Time)

Learning objectives

  • To learn about the evidence-base for lung cancer screening and novel diagnostic modalities
  • To learn about the management of early stage NSCLC and use of adjuvant treatments
  • To understand the role of multi-modality treatment in locally advanced NSCLC and limited stage SCLC
  • To learn about the management of patients with actionable driver mutations and novel targeted agents for advanced NSCLC
  • To understand the role of immune-checkpoint blockade for lung cancer and to learn about novel immunotherapies
  • To learn about treatment of NSCLC with oligometastatic disease
  • To learn about the systemic treatment of mesothelioma and SCLC
  • To learn about the role of supportive and palliative care for thoracic malignancies

Download the preliminary programme 

How to apply

Application is via online form. During the application process you will be required to upload the following:

Application deadline

Applications for this course are now closed.

Who can apply?

While this course is primarily aimed at oncologists resident in Europe, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary registration for this virtual course.

Accreditation

The programme of this event will be accredited with 11 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

  • Fiona Blackhall, United Kingdom
  • Raffaele Califano, United Kingdom
  • Enriqueta Felip, Spain

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings